Market Overview

Stocks Hitting 52-Week Highs

Supernus Announces FDA Acceptance of sNDA to Add Migraine to Trokendi XR Label
A Look Into Supernus Pharma's Investor Day
Related NWSA
Early Global News: Ebola In Liberia, Boeing To Roll Out 737 MAX Next Month, Google Testing SMS Alerts
Benzinga's Top Downgrades
Tribune Publishing +9.6%, denies Murdoch rumor that it's discussing sale (Seeking Alpha)

Supernus Pharmaceuticals (NASDAQ: SUPN) shares jumped 70.75% to create a new 52-week high of $9.75. Supernus Pharmaceuticals received a tentative approval letter from the FDA for Trokendi XR(TM).

News Corp (NASDAQ: NWSA) shares gained 7.59% to touch a new 52-week high of $21.61. News Corp is reportedly considering splitting into two companies.

Asset Acceptance Capital (NASDAQ: AACC) shares rose 5.29% to create a new 52-week high of $6.77. Asset Acceptance Capital joined the Russell 2000 (®), Russell 3000 (®)Russell Global Indexes.

Cambrex (NYSE: CBM) shares gained 1.68% to create a new 52-week high of $8.48. Cambrex's PEG ratio is 0.98.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers


Related Articles (AACC + CBM)

Get Benzinga's Newsletters